A second patent application for novel orexin 1 antagonists has been filed on 25 October 2017. This is an entirely new composition of matter patent supporting our binge eating disorder and alcohol [...]
Chronos CEO, CSO and VP Corporate Development were interviewed at The Telegraph studios recently. Click here to see the interview on our approach to degenerative and behavioural brain disease.
Dr. Merit Cudkowicz is the Julianne Dorn Professor of Neurology at Massachusetts General Hospital, at Harvard Medical School. Dr. Cudkowicz completed medical training at the Health Science and [...]